Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 9424
TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465374BDBM465374(US10793567, Compound 8 | US11225479, Compound 8)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465374BDBM465374(US10793567, Compound 8 | US11225479, Compound 8)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465381BDBM465381(US10793567, Compound 17 | US11225479, Compound 17)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465381BDBM465381(US10793567, Compound 17 | US11225479, Compound 17)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465372BDBM465372(US10793567, Compound 6)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465372BDBM465372(US10793567, Compound 6)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465371BDBM465371(US10793567, Compound 5 | US11225479, Compound 5)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465378BDBM465378(US10793567, Compound 14 | US11225479, Compound 14)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465369BDBM465369(US10793567, Compound 3 | US11225479, Compound 3)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465368BDBM465368(US10793567, Compound 2 | US11225479, Compound 2)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465375BDBM465375(US10793567, Compound 9 | US11225479, Compound 9)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465367BDBM465367(US10793567, Compound 1 | US11225479, Compound 1)
Affinity DataIC50: 2.75E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465380BDBM465380(US10793567, Compound 16 | US11225479, Compound 16)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465380BDBM465380(US10793567, Compound 16 | US11225479, Compound 16)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465379BDBM465379(US10793567, Compound 15)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465379BDBM465379(US10793567, Compound 15)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465378BDBM465378(US10793567, Compound 14 | US11225479, Compound 14)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465377BDBM465377(US10793567, Compound 12 | US11225479, Compound 12)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465377BDBM465377(US10793567, Compound 12 | US11225479, Compound 12)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465376BDBM465376(US10793567, Compound 11 | US11225479, Compound 11)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465376BDBM465376(US10793567, Compound 11 | US11225479, Compound 11)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465375BDBM465375(US10793567, Compound 9 | US11225479, Compound 9)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465373BDBM465373(US10793567, Compound 7 | US11225479, Compound 7)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465373BDBM465373(US10793567, Compound 7 | US11225479, Compound 7)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465371BDBM465371(US10793567, Compound 5 | US11225479, Compound 5)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465370BDBM465370(US10793567, Compound 4 | US11225479, Compound 4)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465370BDBM465370(US10793567, Compound 4 | US11225479, Compound 4)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465369BDBM465369(US10793567, Compound 3 | US11225479, Compound 3)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465368BDBM465368(US10793567, Compound 2 | US11225479, Compound 2)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 465367BDBM465367(US10793567, Compound 1 | US11225479, Compound 1)
Affinity DataIC50: 5.00E+3nMAssay Description:The following describes an assay protocol for measuring the deacetylation of a peptide substrate by the enzymes HDAC2 or HDAC1. Enzyme, substrate, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent